Source: Annual Congress 2010 - Prognosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Mazhak, O. Tkach (Ukraine). Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3102

Member's Comments

No comment yet.

Related content which might interest you: Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002 Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004 Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004 Frequently used inflammation markers and their role in monitoring tuberculosis treatment Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Role of different risk factors in development of recurrent tuberculosis of the lungs in conditions of Uzbekistan Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Role of surgery in treating of firstly-found destructive pulmonary tuberculosis after ineffective DOTS-therapy Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis Source: International Congress 2017 – MDRTB: detection and management Year: 2017 The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003 Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007 Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Aspects of diagnosis and treatment in pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002 Pulmonary function following treatment for pulmonary tuberculosis Source: Annual Congress 2006 - Epidemiology and control of tuberculosis Year: 2006 Rimfampicin importance in tuberculosis treatment Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Pulmonary tuberculosis Source: Respipedia Article Year: 2018 Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002 Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003 Severe pulmonary hypertension in lung disease: phenotypes and response to treatment Source: Eur Respir J 2015; 46: 1378-1389 Year: 2015 Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018 Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Pyrosequencing(PSQ) in early diagnosis of CNS tuberculosis and determining drug resistance. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019